
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Maui, Hawaii - While complaints of "sensitive skin" may be challenging to address, dermatologists can frequently help patients obtain relief, even if there are no overt clinical manifestations to treat, according to Patricia G. Engasser, M.D.